TCR V Beta13.1 anticorps (FITC)

N° du produit ABIN2661440

Cet anticorps anti- est un anticorps Souris Monoclonal détectant dans FACS, IF, CyTOF et IP. Adapté pour Humain.

Aperçu rapide pour TCR V Beta13.1 anticorps (FITC) (ABIN2661440)

Antigène: TCR V Beta13.1

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: FITC

Application: Flow Cytometry (FACS), Immunofluorescence (IF), Cytometry by Time of Flight (CyTOF), Immunoprecipitation (IP)

Clone: H131

Détail du produit

Purification: The antibody was purified by affinity chromatography and conjugated with FITC under optimal conditions. The solution is free of unconjugated FITC and unconjugated antibody.

Isotype: IgG2b kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Protect from prolonged exposure to light. Do not freeze.

Stock: 4 °C

Stockage commentaire: The antibody solution should be stored undiluted between 2°C and 8°C.

Détail du antigène

Antigène: TCR V Beta13.1

Sujet: TCR Vβ13.1 is a variant of the TCR β chain. The receptor is complexed with the TCR α chain and belongs to the immunoglobulin superfamily. It is expressed on a subset of T cells and some T cell clones. Variability in the β chain is generated by Vβ, Dβ, and Jβ gene rearrangement, while variability in the α chain is generated by Vα and Jα rearrangement. TCR Vβ13.1 has been shown to be related to antigen recognition and inflammation as well as diseases, such as HIV and multiple sclerosis.